MORE►
UTSW
Zhijian “James” Chen, Ph.D., a professor of molecular biology at UT Southwestern Medical Center, is a winner of the 2026 Japan Prize in Life Sciences. [Video still: UTSW]
UT Southwestern Biochemist To Receive Prestigious 2026 Japan Prize in Life Sciences
by Sandra Engelland | Jan 21, 2026
Zhijian “James” Chen is receiving the prize for his discoveries about the immune system, including cGAS, which "acts as the body’s burglar alarm to trigger defense from invading pathogens," UTSW said. Numerous winners of the Japan Prize have gone on to win the Nobel Prize for their achievements.
by Sandra Engelland |
Dec 11, 2025
InterAct, which launched inside BioLabs at Pegasus Park, is a preclinical stage biotech company developing AAV8-based gene therapies for metastatic cancer, with an initial focus on breast cancer-derived liver metastases.
MORE►
by Lance Murray |
Jun 16, 2025
The protein—implicated in blood cancers like leukemia, lymphoma, and multiple myeloma—was decoded in near-atomic detail by UT Southwestern researchers, including Nobel Prize winner Bruce Beutler. In lab models, turning off midnolin wiped out up to 92% of cancer cells—with minimal impact on healthy ones, according to UT Southwestern.
MORE►
by David Seeley |
Aug 6, 2024
A study co-led by UTSW's Jin Huk Choi, Ph.D., and Nobel Prize winner Bruce Beutler, M.D., found that targeting a gene-produced protein called ZFP574 "reduced the amount of malignant B cells by as much as 92%." Their findings could lead to new treatments for leukemias and lymphomas—and potentially other cancers, too.
MORE►
UT Southwestern executives Holly Crawford, EVP for business affairs, and Jeremy Falke, vice president and chief human resources officer [Photos: UT Southwestern]
How UT Southwestern Medical Center Nurtures Next-Gen Health Care Leaders
by Quincy Preston | Dec 30, 2022
As one of the nation’s premier academic medical centers, nurturing employees for management and leadership roles is mission critical. The medical center, with its workforce of nearly 23,000, received the 2022 BOLD award for its leadership development.
“As we do with our scientific, medical, and training missions, we apply data-driven strategies to nurture leaders who contribute to our institution’s culture of integrity, inclusiveness, and collaboration, and extend those qualities throughout the organization,” Holly Crawford said.
MORE►
by David Seeley |
Dec 20, 2022
The early-stage startup's QmTRIAGE software platform uses AI and machine learning to detect early breast cancers with a "high rate" of accuracy, MedCognetics says. The company has worked with UT Southwestern and UT Dallas to ensure its AI improves outcomes for "all ethnicities," at a time when racial disparities in AI have become a growing concern.
MORE►
by Lance Murray |
Sep 28, 2022
Over 150 scientists across dozens of departments will be part of the elite National Institutes of Health-funded, university-wide interdisciplinary research center. Dallas' UT Southwestern Medical Center is the only institution in Texas to be selected for the NIH initiative.
UTSW wants to translate scientific discoveries into new therapeutic strategies for the prevention and treatment of obesity, which it describes as a chronic disease affecting more than 40% of the U.S. population, with medical costs nearing $175 billion.
UTSW wants to translate scientific discoveries into new therapeutic strategies for the prevention and treatment of obesity, which it describes as a chronic disease affecting more than 40% of the U.S. population, with medical costs nearing $175 billion.
MORE►
by Dallas Innovates | Staff Report |
Sep 12, 2022
From obesity to cardiovascular disease, we live in an era of unprecedented diet-related health problems. But Dr. Albin, who leads the Culinary Medicine program at UT Southwestern, and her team are trying to cook up a solution by reviewing programs at medical schools across the U.S.
The review of programs by UT Southwestern researchers has been published in Academic Medicine, the journal of the Association of American Medical Colleges.
MORE►
Chen Liu, Ph.D. [Photo: UTSW]
Dallas UTSW Scientists Find Source of Rapid Weight Gain From Antipsychotics
by Quincy Preston | May 13, 2021
Scientist Chen Liu and his colleagues published new findings that suggest a way to counteract the extra weight that can lead patients to stop taking their medication. Possibilities include a recently FDA-approved drug to treat genetic obesity.
MORE►
by Michaela Markels |
Mar 3, 2021
Aaron Fritts, an interventional radiologist, and Gopi Shah, an otolaryngologist, co-founded BackTable in 2016 as a platform for the exchange of ideas, with the hope that it would propel healthcare into the future. Since, the startup has grown to include a podcast that has skyrocketed during the pandemic in terms of demand, scope of expertise, and impact.
MORE►
by Alexa Vickaryous |
Feb 24, 2021
The scientist's research indicates that exercise can reverse thin bones caused by old age, highlighting the importance of older patients staying active.
MORE►
by Alex Edwards |
Feb 3, 2021
The program will offer eight Dallas biotech and life science companies free business training with the hope that they will one day locate their companies to Pegasus Park, a mixed-use social purpose project near the Dallas Design District and the Southwestern Medical District.
MORE►
![This year’s winners from UT Southwestern —Olutoyosi “Toy” Ogunkua, M.D., Luis Sifuentes-Dominguez, M.D, and Chika Nwachukwu, M.D., Ph.D.—bring the total number grants awarded by the Council since its founding five years ago to nine. [Images via UTSW]](https://s24806.pcdn.co/wp-content/uploads/2021/01/UTSW-investigators-940x436.jpg)
This year’s winners named by UT Southwestern's Cary Council—Olutoyosi “Toy” Ogunkua, M.D., Luis Sifuentes-Dominguez, M.D, and Chika Nwachukwu, M.D., Ph.D.—bring the total number grants awarded by the Council since its founding five years ago to nine. [Images via UTSW]
Southwestern Medical Foundation/UTSW Cary Council Awards Grants to Three Early-Stage Researchers
by Alex Edwards | Jan 11, 2021
Members raised nearly $100K in funding for the research awardees who will investigate new evidence-based pathways that can treat some of the world’s most intractable illnesses.
MORE►
by Dave Moore |
Oct 12, 2020
"The downside of a pandemic is that it's frightening. The good thing is, sometimes it speeds up things that probably needed to happen. Like telemedicine," Nicole Small, CEO of LH Capital/Lyda Hill Philanthropies, said during the event.
MORE►
by Quincy Preston |
Oct 8, 2020
This year's Nobel Prize in Chemistry, awarded to two female scientists for the development of CRISPR as a gene-editing tool, is a revolution, according to a pair of UTSW scientists.
UTSW's Eric Olson and Rhonda Bassel-Duby use the technology in their work to treat Duchenne muscular dystrophy. Olson also is the co-founder of biotech Exonics Therapeutics, which exited last year in a deal roughly valued at $1B.
MORE►
by Alex Edwards |
Oct 7, 2020
John Schoggins is one of 10 recipients for the National Institutes of Health's Pioneer Award. The forward-looking researcher is ahead of the curve, beginning the pursuit prior to the current pandemic.
MORE►
